Mitochondrial Medicine - Therapeutic Development

21st-23rd November 2022

Wellcome Genome Campus and virtual

The conference will build new partnerships that harness a greater understanding of disease mechanisms, accelerating the pace of effective treatments for mitochondrial diseases. This year’s meeting will include discussions to improve clinical trial readiness, an update on data analysis for multi-omic studies, the role of mitochondria in cancer, and will explore the links between disease phenotypes and treatments. It will also focus on how patients can be at the heart of clinical trials.

The conference will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in genomics, biochemistry, pathology and clinical medicine.

This conference will be a hybrid meeting – with onsite or virtual attendance.

For more information and to register please click here.